Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 58,496,000 | 100,330,000 | 81,288,000 | 41,651,000 | 40,905,000 |
| Cost of Goods | 24,954,000 | 34,344,000 | 30,821,000 | 8,484,000 | 8,054,000 |
| Gross Profit | 33,542,000 | 65,986,000 | 50,467,000 | 33,167,000 | 32,851,000 |
| Operating Expenses | 33,320,000 | 31,042,000 | 31,034,000 | 24,917,000 | 26,141,000 |
| Operating Income | 222,000 | 34,944,000 | 19,433,000 | 8,250,000 | 6,710,000 |
| Other Income | 836,000 | -215,000 | 4,878,000 | -1,214,000 | 4,611,000 |
| Pre-tax Income | 1,058,000 | 34,729,000 | 24,311,000 | 7,036,000 | 11,321,000 |
| Income Tax | -1,115,000 | 3,328,000 | 1,852,000 | 370,000 | 583,000 |
| Net Income Continuous | 2,172,000 | 31,401,000 | 22,459,000 | 6,666,000 | 10,738,000 |
| Net Income Discontinuous | -15,000 | 6,000 | -434,000 | 2,529,000 | 5,318,000 |
| Minority Interests | 39,000 | 35,000 | 45,000 | 36,000 | 29,000 |
| Net Income | $2,119,000 | $31,372,000 | $21,980,000 | $9,159,000 | $16,027,000 |
| EPS Basic Total Ops | 0.38 | 5.59 | 3.92 | 1.65 | 2.88 |
| EPS Basic Continuous Ops | 0.38 | 5.59 | 4.00 | 1.19 | 1.92 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | -0.08 | 0.46 | 0.95 |
| EPS Diluted Total Ops | 0.37 | 5.47 | 3.85 | 1.63 | 2.82 |
| EPS Diluted Continuous Ops | 0.37 | 5.47 | 3.93 | 1.18 | 1.89 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | -0.08 | 0.45 | 0.94 |
| EPS Diluted Before Non-Recurring Items | 1.84 | 6.58 | 4.42 | 2.22 | 2.95 |
| EBITDA(a) | $6,512,000 | $40,008,000 | $24,624,000 | $12,931,000 | $12,465,000 |